Mylan Asks Fed. Circ. To Flip PTAB's Ruling On Merck Patent
Drugmaker Mylan is urging the Federal Circuit to overturn the Patent Trial and Appeal Board's "error riddled" decision to uphold a patent on Merck's blockbuster diabetes drug Januvia, faulting the board...To view the full article, register now.
Already a subscriber? Click here to view full article